Leading Professional Society for Computational Biology and Bioinformatics
Connecting, Training, Empowering, Worldwide


CHI’s Structure-Based Design: Sophisticated Approaches to Drug Discovery
United States - MA - Boston

Hosted by:Cambridge Healthtech Institute
Venue:The World Trade Center
Dates:Jun 06, 2007 through Jun 08, 2007

Call for Posters:2007-01-15 through 2007-05-17
Event Registration:2007-01-01 through 2007-06-06
Early Registration Deadline:2007-03-09
 Keynote Presentation by Mark Murcko, Ph.D.
 Pre-Conference Short Course: Designing Kinase Inhibitors
 Cutting-Edge Scientific Sessions
 2 Panel Discussions:
- What Do We Mean by (Traditional) Structure-Based Drug Design?
- Lessons to Take Home
 Case Studies & Examples of Successful Structural Designs
 and more!

Scientific Advisory Board:
Celerino Abad-Zapatero, Ph.D., Associate Research Fellow, Protein Crystallography Laboratory, Abbott Laboratories

Richard A. Friesner, Ph.D., Professor of Chemistry, Columbia University

Klaus Mueller, Ph.D., Head of Science & Technology Relations, Pharmaceutical Research, F. Hoffmann La- Roche AG

Mark Murcko, Ph.D., Vice President & Chief Technology Officer, Scientific Advisory Board, Vertex Pharmaceuticals Inc.

Tomi K. Sawyer, Ph.D., Senior Director, Chemical Sciences, Pfizer Research Technology Center
Additional Information
Event URL:http://www.healthtech.com/2007/SBD
ISCB Member Discount:10 percent
Contact Person:James Prudhomme ([javascript protected email address])

While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.